4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)
暂无分享,去创建一个
R. Greil | M. Gnant | H. Samonigg | R. Jakesz | E. Kubista | G. Steger | C. Marth | B. Mlineritsch | A. Lang | E. Melbinger-Zeinitzer